Search Results

Editorial Comment to Impact of low‐dose tadalafil on adverse events after low‐dose‐rate brachytherapy for prostate cancer: A bi‐center randomized open‐label trial.

• Authors : Haga, Nobuhiro¹ (AUTHOR) ; Miyazaki, Takeshi¹ (AUTHOR); Tsubouchi, Kazuna¹ (AUTHOR)

Subjects: *LOW dose rate brachytherapy; *TADALAFIL; *PROSTATE cancer

• Source: International Journal of Urology. Apr2021, Vol. 28 Issue 4, p438-439. 2p.

Record details

Impact of low‐dose tadalafil on adverse events after low‐dose‐rate brachytherapy for prostate cancer: A bi‐center randomized open‐label trial.

• Authors : Minagawa, Tomonori (AUTHOR); Oguchi, Tomohiko (AUTHOR); Saitou, Tetsuichi (AUTHOR)

Subjects: RADIOISOTOPE brachytherapy; TADALAFIL; PROSTATE cancer

• Source: International Journal of Urology. Apr2021, Vol. 28 Issue 4, p432-438. 7p.

Record details

Tadalafil and Steroid Hormones Interactions in Adipose, Bone and Prostate Tissues: Focus on Translational Perspectives.

• Authors : Greco, Emanuela Alessandra; Antinozzi, Cristina; Di Luigi, Luigi

Subjects: TADALAFIL; STEROID hormones; ANDROGEN receptors

• Source: International Journal of Molecular Sciences; Apr2022, Vol. 23 Issue 8, p4191-4191, 12p

Record details

Prostate Cancer.

Subjects: *PROSTATE cancer; *TADALAFIL; *CYCLIC nucleotide phosphodiesterase inhibitors

• Source: Current Medical Literature: Urology. 2012, Vol. 18 Issue 1, p24-27. 4p.

Record details

Impact of postoperative phosphodiesterase type 5 inhibitor treatment on lower urinary tract symptoms after robot-assisted radical prostatectomy: a longitudinal study.

• Authors : Honda, Masashi¹ (AUTHOR) ; Kawamoto, Bunya¹ (AUTHOR); Morizane, Shuichi¹ (AUTHOR)

Subjects: *PHOSPHODIESTERASE-5 inhibitors; *TADALAFIL; *PROSTATECTOMY

• Source: Scandinavian Journal of Urology (Taylor & Francis Ltd). Feb2017, Vol. 51 Issue 1, p33-37. 5p.

Record details

Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy.

• Authors : Moncada, Ignacio; Bethencourt, Fermín; Lledó-García, Enrique

Subjects: PROSTATECTOMY; TADALAFIL; PLACEBOS

• Source: World Journal of Urology; Jul2015, Vol. 33 Issue 7, p1031-1038, 8p

Record details

Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV study.

• Authors : Patel, Hitendra R.; Ilo, Dapo; Shah, Nimish

Subjects: PROSTATE surgery; TADALAFIL; ADENOCARCINOMA

• Source: BMC Urology; 2015, Vol. 15 Issue 1, p1-10, 10p

Record details

Do baseline estrogen and testosterone affect lower urinary tract symptoms (LUTS) prior to or after pharmacologic treatment with tadalafil?

• Authors : Egan, K. B.; Miner, M. M.; Suh, M.

Subjects: ESTROGEN; TESTOSTERONE; URINARY tract infections

• Source: Andrology. Nov2015, Vol. 3 Issue 6, p1165-1172. 8p.

Record details

Effect of surgical approach on erectile function recovery following bilateral nerve-sparing radical prostatectomy: an evaluation utilising data from a randomised, double-blind, double-dummy multicentre trial of tadalafil vs placebo.

• Authors : Stolzenburg, Jens‐Uwe; Graefen, Markus; Kriegel, Christian

Subjects: IMPOTENCE; PROSTATECTOMY; TADALAFIL

• Source: BJU International; Aug2015, Vol. 116 Issue 2, p241-251, 11p

Record details

Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.

• Authors : Montorsi, Francesco¹ ; Oelke, Matthias²; Henneges, Carsten³

Subjects: *TADALAFIL; *PLACEBOS; *PROSTATECTOMY

• Source: European Urology. Sep2016, Vol. 70 Issue 3, p529-537. 9p.

Record details